WILLIAMS KRISTEN — SEC insider filings

SEC reporting owner CIK 1296965. 22 insider filings on record with FilingPulse; latest filed 2026-11-17.

Transaction summary — filings shown

Covers all 22 filings on record, filed 2020-09-17 to 2026-11-17. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Pacira BioSciences, Inc. (PCRX)Chief Administrative Officer22—30 legs · 214,938 sh · $11,454,39185

Insider filings — WILLIAMS KRISTEN

FiledFormIssuerReported transactionsSource
2026-11-174Pacira BioSciences, Inc. (PCRX)Disposition to issuer (D): 167,062 @ $36.50 · Disposition to issuer (D): 2,953 (derivative) · Disposition to issuer (D): 10,560 (derivative) · Disposition to issuer (D): 19,685 (derivative) · Disposition to issuer (D): 17,500 (derivative) · Disposition to issuer (D): 24,800 (derivative) · +1 moreEDGAR
2026-06-054Pacira BioSciences, Inc. (PCRX)Tax withholding (F): 8,528 @ $22.32 · Sale (S): 10,259 @ $22.27EDGAR
2026-02-134Pacira BioSciences, Inc. (PCRX)Grant/award (A): 54,546 @ $0EDGAR
2026-02-034Pacira BioSciences, Inc. (PCRX)Tax withholding (F): 17,134 @ $20.54 · Sale (S): 13,137 @ $20.53EDGAR
2025-06-054Pacira BioSciences, Inc. (PCRX)Tax withholding (F): 6,162 @ $26.40 · Sale (S): 14,376 @ $26.24EDGAR
2025-02-044Pacira BioSciences, Inc. (PCRX)Grant/award (A): 79,200 @ $0EDGAR
2024-06-134Pacira BioSciences, Inc. (PCRX)Grant/award (A): 54,300 @ $0 · Sale (S): 7,452 @ $28.38EDGAR
2024-06-054Pacira BioSciences, Inc. (PCRX)Tax withholding (F): 3,011 @ $30.89EDGAR
2024-02-074Pacira BioSciences, Inc. (PCRX)Grant/award (A): 33,700 @ $0EDGAR
2023-06-164Pacira BioSciences, Inc. (PCRX)Grant/award (A): 10,950 @ $0 · Sale (S): 6,467 @ $37.03 · Grant/award (A): 27,500 (derivative) @ $0EDGAR
2023-06-074Pacira BioSciences, Inc. (PCRX)Sale (S): 1,301 @ $38.99 · Sale (S): 1,357 @ $37.87EDGAR
2022-06-084Pacira BioSciences, Inc. (PCRX)Sale (S): 3,969 @ $61.37 · Sale (S): 4,649 @ $59.51 · Grant/award (A): 9,900 @ $0 · Grant/award (A): 24,800 (derivative) @ $0EDGAR
2022-03-234Pacira BioSciences, Inc. (PCRX)Option exercise (M): 2,953 @ $38.35 · Option exercise (M): 2,112 @ $43.54 · Option exercise (M): 2,188 @ $47.65 · Sale (S): 7,253 @ $72.67 · Option exercise (M): 2,953 (derivative) @ $0 · Option exercise (M): 2,112 (derivative) @ $0 · +1 moreEDGAR
2022-03-014Pacira BioSciences, Inc. (PCRX)Option exercise (M): 10 @ $38.35 · Sale (S): 10 @ $65 · Option exercise (M): 2,050 @ $38.35 · Sale (S): 50 @ $65 · Sale (S): 2,000 @ $67.07 · Option exercise (M): 10 (derivative) @ $0 · +1 moreEDGAR
2022-02-144Pacira BioSciences, Inc. (PCRX)Option exercise (M): 800 @ $38.35 · Sale (S): 800 @ $65.18 · Option exercise (M): 800 (derivative) @ $0EDGAR
2022-02-084Pacira BioSciences, Inc. (PCRX)Option exercise (M): 1,000 @ $38.35 · Sale (S): 1,000 @ $65.18 · Option exercise (M): 1,000 (derivative) @ $0EDGAR
2022-01-254Pacira BioSciences, Inc. (PCRX)Option exercise (M): 200 @ $38.35 · Sale (S): 200 @ $65.41 · Option exercise (M): 200 (derivative) @ $0EDGAR
2022-01-204Pacira BioSciences, Inc. (PCRX)Option exercise (M): 1,375 @ $44.20 · Option exercise (M): 2,600 @ $38.35 · Option exercise (M): 6,338 @ $43.54 · Option exercise (M): 13,127 @ $47.65 · Sale (S): 23,040 @ $65.24 · Sale (S): 400 @ $66.14 · +7 moreEDGAR
2021-06-114Pacira BioSciences, Inc. (PCRX)Grant/award (A): 7,000 @ $0 · Sale (S): 4,842 @ $59.43 · Sale (S): 847 @ $60.57 · Grant/award (A): 17,500 (derivative) @ $0EDGAR
2021-06-084Pacira BioSciences, Inc. (PCRX)Sale (S): 3,930 @ $61.04EDGAR
2021-04-154Pacira BioSciences, Inc. (PCRX)Option exercise (M): 2,500 @ $32.35 · Option exercise (M): 4,125 @ $44.20 · Option exercise (M): 8,859 @ $38.35 · Option exercise (M): 6,339 @ $43.54 · Sale (S): 14,793 @ $66.40 · Sale (S): 7,030 @ $68.11 · +4 moreEDGAR
2020-09-174Pacira BioSciences, Inc. (PCRX)Option exercise (M): 5,832 @ $40.34 · Option exercise (M): 5,832 @ $32.35 · Option exercise (M): 5,499 @ $44.20 · Option exercise (M): 7,874 @ $38.35 · Option exercise (M): 2,816 @ $43.54 · Sale (S): 14,622 @ $59.01 · +30 moreEDGAR

FilingPulse's Form 4 archive currently extends back to 2020-09-16 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1296965 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs